HF
GRI

HRT Financial’s GRI Bio GRI Stock Holding History

HRT Financial’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29
Closed -$5K – 2705
2024
Q3 		$5K Buy
+29
New +$11.7K ﹤0.01% 2269
2024
Q2 		– Sell
-3
Closed -$14K – 2535
2024
Q1 		$14K Buy
3
+2
+200% +$17.1K ﹤0.01% 2038
2023
Q4 		$9K Buy
+1
New +$41.7K ﹤0.01% 2090

Other funds holding GRI

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's GRI Position: Q4 2024 in Review

HRT Financial sold out of GRI Bio (GRI) in Q4 2024, closing a stake of 29 shares — an estimated $5K sold.

HRT Financial first reported a position in GRI in Q4 2023 and held it in 3 quarters. The position peaked at $14K in Q1 2024. 7 funds tracked by Wall St. Rank hold GRI as of Q4 2024.

  • HRT Financial reported no remaining GRI Bio position as of Q4 2024 after selling out during the quarter.
  • HRT Financial sold 29 GRI Bio shares in Q4 2024, an estimated $5K.
  • HRT Financial first reported a position in GRI Bio in Q4 2023 and held it in 3 quarters.
  • HRT Financial's GRI Bio position peaked at $14K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held GRI Bio as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.